Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), bought 2,950 shares at $28.00 ($83K) on 2020-06-18, disclosed to the SEC on 2020-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 1,450 | $41K | 49.2% |
| 2 | $28.00 | 1,500 | $42K | 50.8% |
| Total | $28.00 avg | 2,950 | $83K | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |